German pharmaceutical company Bayer AG says it has completed its purchase of U.S. seed and weed-killer maker Monsanto Co., reports the Tampa Bay Times.
Bayer said Thursday that it is now the sole owner of the company and Monsanto shares will no longer trade on the New York Stock Exchange.
Bayer has put the cost of the deal at some $63 billion including debt.
